Sonova H (Switzerland) Insiders
SOON Stock | CHF 312.10 8.10 2.66% |
Sonova H employs about 17.1 K people. The company is managed by 10 executives with a total tenure of roughly 39837 years, averaging almost 3983.0 years of service per executive, having 1707.3 employees per reported executive. Recap of Sonova H's management performance can provide insight into the venture performance.
Christophe Fond Insider Group Board |
Robert Woolley Insider Group Board |
Sonova |
Sonova H Management Team Effectiveness
The company has return on total asset (ROA) of 0.0879 % which means that it generated a profit of $0.0879 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2878 %, meaning that it generated $0.2878 on every $100 dollars invested by stockholders. Sonova H's management efficiency ratios could be used to measure how well Sonova H manages its routine affairs as well as how well it operates its assets and liabilities.Sonova H Workforce Comparison
Sonova H Ag is rated below average in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is at this time estimated at about 79,489. Sonova H totals roughly 17,073 in number of employees claiming about 21% of all equities under Medical Instruments & Supplies industry.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21. Sonova H Ag Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sonova H Ag Price Series Summation is a cross summation of Sonova H price series and its benchmark/peer.
Sonova H Notable Stakeholders
A Sonova H stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sonova H often face trade-offs trying to please all of them. Sonova H's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sonova H's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Christophe Fond | Group Board | Profile | |
Robert Woolley | Group Board | Profile | |
Ludger Althoff | Group Board | Profile | |
Jan Metzdorff | Pres US | Profile | |
Arnd Kaldowski | COO CEO | Profile | |
Claudio Bartesaghi | Group Board | Profile | |
Thomas Bernhardsgrutter | Director Relations | Profile | |
Martin Grieder | Group Board | Profile | |
Birgit Conix | CFO Board | Profile | |
Victoria CarrBrendel | Group Board | Profile |
About Sonova H Management Performance
The success or failure of an entity such as Sonova H Ag often depends on how effective the management is. Sonova H management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sonova management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sonova management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. Sonova Holding AG was founded in 1947 and is headquartered in Stfa, Switzerland. SONOVA N operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 14740 people.
Please note, the imprecision that can be found in Sonova H's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sonova H Ag. Check Sonova H's Beneish M Score to see the likelihood of Sonova H's management manipulating its earnings.
Sonova H Workforce Analysis
Traditionally, organizations such as Sonova H use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sonova H within its industry.Sonova H Manpower Efficiency
Return on Sonova H Manpower
Revenue Per Employee | 197K | |
Revenue Per Executive | 336.4M | |
Net Income Per Employee | 38K | |
Net Income Per Executive | 64.9M |
Additional Tools for Sonova Stock Analysis
When running Sonova H's price analysis, check to measure Sonova H's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonova H is operating at the current time. Most of Sonova H's value examination focuses on studying past and present price action to predict the probability of Sonova H's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonova H's price. Additionally, you may evaluate how the addition of Sonova H to your portfolios can decrease your overall portfolio volatility.